LMG Life Sciences Awards EMEA 2024: key dates revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2024: key dates revealed

LMG Life Sciences Awards 2024 EMEA _ bkgrd_4x.png

Key dates for the LMG Life Sciences EMEA research for 2024 have been released

The LMG Life Sciences Awards EMEA is excited to announce its return for its fifth year and reveal its key dates for the 2024 research. The Awards will be open for submissions starting December 7.

Please note the following dates in your calendars:

Nominations Open

Nominations Close

Shortlist Published

Gala Ceremony

7 December 2023

25 January 2024

March 2024

May 2024


The life sciences industry will be invited to provide nominations for leading practitioners, firms, cases and deals. The Awards will recognise the most outstanding work completed by private practice law firms, as well as in-house legal teams and counsels during 2023.

If you have any questions about the research, please contact the LMG Life Sciences awards editor, John Harrison.

LMG Life Sciences produces the most respected awards programme for life sciences practitioners and law firms across Europe, the Middle East, and Africa. Honourees are determined through a rigorous research process that aims to recognise and celebrate excellent legal work and client service over a 12-month period.

The awards span four broad practice areas: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement.

In addition to award categories for firms and individuals, an array of unique awards are announced each year to highlight the achievements of in-house teams and to celebrate Impact Cases and Deals of the Year.

Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IP Stars research.

more from across site and SHARED ros bottom lb

More from across our site

A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
Gift this article